Episódios
-
Dr. Henry continues his discussion by giving an overview of classes of pharmacologic therapies, and their effects on different blood lipids. He also reviews key recommendations from guidelines regarding the treatment of dyslipidemia, reviews key clinical trials, and provides up-to-date information on recent and ongoing trials.
-
In this segment, Robert Henry, MD, discusses risk factors related to blood lipids, predictors of risk beyond LDL-C, recommendations for lipid levels, and customizing goals for therapy, in patients with type 2 diabetes.
-
Estão a faltar episódios?